Stereotactic Body Radiation Therapy in Nonsurgical Patients with Metastatic Spinal Disease and Epidural Compression: A Retrospective Review.

Epidural disease Malignant spinal cord compression (MSCC) Spinal metastases Stereotactic ablative body radiotherapy (SABR) Stereotactic body radiation therapy (SBRT)

Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 27 08 2018
accepted: 26 09 2018
pubmed: 12 10 2018
medline: 6 3 2019
entrez: 12 10 2018
Statut: ppublish

Résumé

In the setting of spinal metastases with epidural cord compression, radiosurgery is often only considered when there is sufficient separation between the epidural disease and the spinal cord. However, in patients who are nonsurgical candidates or those who prefer nonoperative management, there may be a benefit from stereotactic body radiation therapy, even when the epidural target is closer than the traditionally referenced 3 mm distance from the spinal cord. The purpose of this retrospective study is to evaluate our institution's experience in treating 20 such patients. We reviewed records of all patients treated with stereotactic body radiation therapy for spinal metastases at our institution from January 2010 to January 2016, with follow-up through December 2016. The primary end point was local progression of disease. Local progression was defined as clear radiographic disease growth on follow-up imaging or worsening clinical symptoms in the absence of evidence for radiation myelopathy. Local control was obtained in 55% of patients meeting these criteria without a single case of radiation myelitis. Most patients with disease progression were able to undergo additional local treatment. Although local control was less than expected when compared with spine radiosurgery with adequate separation between the target and spinal cord, this treatment appears to be a viable option in the nonsurgical candidate.

Sections du résumé

BACKGROUND BACKGROUND
In the setting of spinal metastases with epidural cord compression, radiosurgery is often only considered when there is sufficient separation between the epidural disease and the spinal cord. However, in patients who are nonsurgical candidates or those who prefer nonoperative management, there may be a benefit from stereotactic body radiation therapy, even when the epidural target is closer than the traditionally referenced 3 mm distance from the spinal cord. The purpose of this retrospective study is to evaluate our institution's experience in treating 20 such patients.
METHODS METHODS
We reviewed records of all patients treated with stereotactic body radiation therapy for spinal metastases at our institution from January 2010 to January 2016, with follow-up through December 2016. The primary end point was local progression of disease. Local progression was defined as clear radiographic disease growth on follow-up imaging or worsening clinical symptoms in the absence of evidence for radiation myelopathy.
RESULTS RESULTS
Local control was obtained in 55% of patients meeting these criteria without a single case of radiation myelitis. Most patients with disease progression were able to undergo additional local treatment.
CONCLUSIONS CONCLUSIONS
Although local control was less than expected when compared with spine radiosurgery with adequate separation between the target and spinal cord, this treatment appears to be a viable option in the nonsurgical candidate.

Identifiants

pubmed: 30308345
pii: S1878-8750(18)32265-4
doi: 10.1016/j.wneu.2018.09.210
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e198-e205

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Ahmed Meleis (A)

Department of Neurological Surgery, Rutgers-New Jersey Medical School, Newark, New Jersey, USA. Electronic address: meleisah@njms.rutgers.edu.

Sachin R Jhawar (SR)

Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

Joseph P Weiner (JP)

Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

Neil Majmundar (N)

Department of Neurological Surgery, Rutgers-New Jersey Medical School, Newark, New Jersey, USA.

Aria Mahtabfar (A)

Department of Neurosurgery, Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

Yong Lin (Y)

Department of Biostatistics, Rutgers School of Public Health, Piscataway, New Jersey, USA.

Salma Jabbour (S)

Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

Shabbar Danish (S)

Department of Neurosurgery, Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

Sharad Goyal (S)

Department of Radiation Oncology, George Washington University Cancer Center, Washington DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH